Figma's stock faced a steep sell-off in January, mirroring a broader downturn in SaaS stocks driven by investor concerns over AI disruption and sector-wide valuation pressures.
After years of declining share prices, Pfizer is banking on a pipeline packed with over 20 pivotal Phase 3 trial launches this year to reignite growth and investor confidence.
Despite posting explosive revenue and earnings growth, UP Fintech Holding Limited trades at a significant discount. Analysts point to its successful pivot to Singapore and Hong Kong, robust balance sheet, and a potential 87% upside as catalysts for a major re-rating.
Shares of infrastructure specialist Quanta Services (PWR) defied a broader market downturn, rising over 2% as investors position for the company's upcoming earnings report. The rally extends a strong year-to-date performance, but analysts question if the current price fully reflects future growth prospects.
The financial technology provider's latest integrations for its Banno Digital Platform aim to deliver richer data and embedded controls for community banks and credit unions, potentially strengthening client retention in a competitive landscape.
Six years after their rescue from a childhood of unimaginable torture, the Turpin siblings are reclaiming their narrative. In a new interview, three of the youngest survivors speak publicly for the first time, detailing their journey toward healing and the unbreakable bond that sustains them.
As Teva Pharmaceutical shifts focus from its legacy generics business to a promising innovative pipeline, its experimental drug Duvakitug emerges as a potential valuation catalyst. We examine the bull case, the competitive landscape, and what it means for investors.
After years of investor skepticism over heavy losses, hydrogen fuel cell pioneer Plug Power is showing early signs of operational and financial discipline. With a streamlined strategy and reinforced balance sheet, the company aims to transition from a cash-burn narrative to one of execution and margin improvement.
Despite being battered by market pessimism, Polestar Automotive is drawing attention from contrarian investors who see its deep ties to automotive giant Geely as a potential lifeline. With billions in revenue and a powerful backer, the question is whether this EV brand can navigate its cash burn and tariff challenges.
Ripple's acquisition of a full Electronic Money Institution license in Luxembourg marks a significant regulatory milestone for its European expansion. However, the price of its associated XRP token continues to slide, underscoring a persistent disconnect between corporate progress and crypto market sentiment.
Benchmark Electronics (BHE) delivered a strong finish to fiscal 2025, with Q4 revenue and earnings surpassing guidance. The company highlighted improving margins, robust cash generation, and growth in key sectors, even as it navigates a planned CEO transition and outlines increased capital investment for the year ahead.
After navigating past strategic missteps, online automotive marketplace CarGurus (CARG) is emerging as a leaner, more focused business. With a dominant market position, pricing power, and a cyclical recovery in the used car sector on the horizon, analysts see significant upside potential for the stock.
SiTime Corporation (SITM) is gaining renewed attention on Wall Street, with UBS and Barclays raising their price targets significantly. Analysts point to the company's strategic pivot towards AI-focused timing solutions as a key driver for improved financial prospects.
Advanced Micro Devices (AMD) garners a reiterated Buy rating and $300 price target from Susquehanna, with strong data center demand and the upcoming MI450 AI accelerator seen as key growth drivers for the semiconductor giant.
Recent analyst reports from Wells Fargo and H.C. Wainwright suggest consensus revenue estimates for biotech firm Argenx SE may be too conservative, with key drug Vyvgart poised to outperform expectations through 2030.
UBS and Wells Fargo have trimmed their price targets for chip designer Arm Holdings, citing near-term revenue adjustments. Despite the revisions, both firms maintain bullish Buy ratings, underscoring confidence in Arm's pivotal role in the expanding artificial intelligence ecosystem.
As AI-driven electricity demand soars, NuScale Power's certified small modular reactor technology positions it at the forefront of a potential energy transformation. While its path is paved with both landmark agreements and significant execution risks, investors are weighing whether this pre-revenue company can power the future.
Fintech firm Figure Technology Solutions (FIGR) is drawing investor attention with its blockchain-powered platform for loan origination and digital assets. While its growth metrics and partner adoption are strong, its high P/E ratio raises questions about its long-term potential in a competitive market.
Despite a landmark deal to bring tokenized U.S. stocks and ETFs into MetaMask, Ondo Finance's ONDO token remains mired in a 37% monthly slump, underscoring the stark disconnect between real-world asset protocol growth and governance token performance.
A federal investigation is underway following the discovery of a suspected biological laboratory in a Las Vegas home, with authorities linking the property to a Chinese national already facing federal charges in a separate California biolab case. The property manager has been arrested on hazardous waste charges.
